semaglutide back bay Tampa Back pain from rapid weight
Description
Research suggests 20-30% of GLP-1 users experience suboptimal responses, driven by dosing protocols, adherence patterns, metabolic factors, and individual genetic predispositions
How Long Can You Take Semaglutide
Psychological factors also contribute to plateaus
Forbes has reached out to Eli Lilly, the maker of Mounjaro and Zepbound, for comment
